Thane FDA sends show-cause notice to Wanbury Pharma

MUMBAI: The Thane Food and Drug Administration on Wednesday said it has sent a show cause notice to Mumbai-based Wanbury Pharma for illegal export of Metformin Hyrdrochlodride, a diabetes drug. “We have sent a show cause notice to the company and are waiting for a reply,” said Viraj Paunikar, Assistant Commissioner, Thane FDA, in an telephonic conversation with ET.

Wanbury is under lens for illegally exporting the API to Mexico, Brazil and Pakistan. Wanbury had low production capacity to make them and outsourced it to Pharmaceutical Products of India.